首页> 外文期刊>Current Plant Biology >Challenges and future directions of potential natural products leads against 2019-nCoV outbreak
【24h】

Challenges and future directions of potential natural products leads against 2019-nCoV outbreak

机译:潜在的天然产品的挑战和未来方向导致2019年 - NCOV爆发

获取原文
           

摘要

Except for Remdesivir? no other drug or vaccine has yet been approved to treat the coronavirus disease (COVID-19) caused by the virus known as, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Remdesivir? an small molecule and nucleic acid analogue, it is used to treat adults and children with laboratory confirmed COVID-19, only administrated in hospital settings. Small molecules and particularly natural products count for almost fifty percent of the commercially available drugs, several of them are marketed antiviral agents and those can be a potential agent to treat COVID-19 infections. This short review rationalized different key natural products with known activity against coronaviruses as potential leads against COVID-19.
机译:除了remdesivir吗?尚未批准其他药物或疫苗治疗由已知的病毒引起的冠状病毒病(Covid-19),严重急性呼吸综合征冠状病毒2(SARS-COV-2)。 Remdesivir?小分子和核酸类似物,用于治疗实验室确认的Covid-19的成人和儿童,只能在医院环境中给药。小分子和特别是天然产品的数量近50%的市售药物,其中几种是销售的抗病毒药物,而且可以是治疗Covid-19感染的潜在剂。此简短评论合理化了不同关键的天然产物,具有针对冠状病毒的已知活性,因为潜在导致Covid-19。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号